APA

Bernuth S., Grimm D., Vollmar J., Darstein F., Mittler J., Heise M., Hoppe-Lotichius M., Galle P. R., Lang H. & Zimmermann T. (20180614). Efficacy and safety of direct-acting antiviral therapy in previous hard-to-treat patients with recurrent hepatitis C virus infection after liver transplantation: a real-world cohort. : Drug design, development and therapy.

Chicago

Bernuth Sebastian, Grimm Daniel, Vollmar Johanna, Darstein Felix, Mittler Jens, Heise Michael, Hoppe-Lotichius Maria, Galle Peter R, Lang Hauke and Zimmermann Tim. 20180614. Efficacy and safety of direct-acting antiviral therapy in previous hard-to-treat patients with recurrent hepatitis C virus infection after liver transplantation: a real-world cohort. : Drug design, development and therapy.

Harvard

Bernuth S., Grimm D., Vollmar J., Darstein F., Mittler J., Heise M., Hoppe-Lotichius M., Galle P. R., Lang H. and Zimmermann T. (20180614). Efficacy and safety of direct-acting antiviral therapy in previous hard-to-treat patients with recurrent hepatitis C virus infection after liver transplantation: a real-world cohort. : Drug design, development and therapy.

MLA

Bernuth Sebastian, Grimm Daniel, Vollmar Johanna, Darstein Felix, Mittler Jens, Heise Michael, Hoppe-Lotichius Maria, Galle Peter R, Lang Hauke and Zimmermann Tim. Efficacy and safety of direct-acting antiviral therapy in previous hard-to-treat patients with recurrent hepatitis C virus infection after liver transplantation: a real-world cohort. : Drug design, development and therapy. 20180614.